BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/15/2016 3:02:00 PM | Browse: 1902 | Download: 2592
Publication Name World Journal of Gastroenterology
Manuscript ID 18092
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title New blood markers detection technology: A leap in the diagnosis of gastric cancer
Manuscript Source Invited Manuscript
All Author List Maneesh K Beeharry, Wen-tao Liu, Min Yan and Zheng-gang Zhu
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 30872477
National Natural Science Foundation of China 30901729
Corresponding Author Wen-tao Liu, MD, PhD, Key Laboratory of Shanghai Gastric Neoplasms, Department of Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University, 197 Ruijin Road II, Shanghai 200025, China. wt_mygod@163.com
Key Words Gastric cancer; Circulating tumor cells; Circulating tumor DNA; Proteomics; Biomarkers; Methylation
Core Tip Gastric cancer (GC)’s poor prognosis has partly been a result of its late diagnosis due to its asymptomatic and nonspecific symptoms in its early stages. Tremendous advances in the OMICS technology have allowed the development of several methods helping to understand the mechanisms underlying gastric carcinogenesis, resulting in the identification of a large number of molecular targets such as circulating tumor cells, cell free DNA, cell tumor DNA and their sub-molecular components such as miRNA that show great promise as GC biomarkers. In this review, we are underlying the recent breakthroughs about new blood markers technology for GC while scrutinizing their potential clinical use in the pathogenesis, diagnosis and management of GC.
Publish Date 2016-01-15 14:54
Citation Beeharry MK, Liu WT, Yan M, Zhu ZG. New blood markers detection technology: A leap in the diagnosis of gastric cancer. World J Gastroenterol 2016; 22(3): 1202-1212
URL http://www.wjgnet.com/1007-9327/full/v22/i3/1202.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i3.1202
Full Article (PDF) WJG-22-1202.pdf
Full Article (Word) WJG-22-1202.doc